Early-stage Immuno Vaxiion Therapeutics is a small bio startup in San Diego focused on cancer immunotherapies with a current team of 2-10 employees, signaling an opportunity to engage early with their business development channel and support scalable partnerships.

Clinical Pipeline They emphasize translating science into improved patient outcomes and invite inquiries about their pipeline and clinical trials, suggesting potential collaboration on research partnerships, co-development, or sponsored trial opportunities.

Funding Signals Reported revenue in the low seven figures indicates a developing commercial footprint; engaging on strategic funding, grant opportunities, or venture funding introductions could align with their growth trajectory.

Tech Footprint Their technology stack is common for web presence and internal operations rather than research infrastructure, implying opportunities around digital health partnerships, data management, patient engagement platforms, or website-based lead generation support.

Competitive Context In a field with similarly sized players and several peers with modest revenues, Vaxiion may benefit from partnerships in manufacturing, clinical trial logistics, or downstream commercialization services to accelerate time to impact.